Sofinnova Investments

Sofinnova Investments specializes in seed, startup, mid, early stage, series A, first venture round, and corporate spinouts.

Business Model: B2B

Revenue: $20M

Employees: 11-50

Rankings

Detailed Sofinnova Investments Information

Geographic Data

Sofinnova Investments headquarters map

Address: 3000 Sand Hill Rd

City: Menlo Park

State: CA

Zip: 94025

Country: US

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$2B

Metrics

3,162,613Website Global Rank

5,125Website Monthly Traffic

Twitter Followers

Description

Sofinnova Ventures has partnered with entrepreneurs to secure initial funding, build successful teams, win key customers, and navigate acquisitions and IPOs. Sofinnova Ventures invests in Life Science and Technology start-ups. Their professionals are seasoned business operators, possessing deep domain and investment expertise. They know how to help entrepreneurs build successful, global businesses.

Contact Phone:
+16506818420

Contact Email:

Announced Date Company Transaction Money Raised
10/2002 Laszlo Systems Venture Round 9M
5/2014 Sorbent Therapeutics Series D 0
6/2011 Sorbent Therapeutics Series B 0
1/2020 Vera Therapeutics Venture Round -
1/2021 Visen Pharmaceuticals Series B 0
10/2013 Versartis Series D 0
1/2002 Prestwick Pharmaceuticals Venture Round -
1/1998 Pharmasonics Venture Round -
1/2000 Infovista Venture Round 0
11/2004 Ascenta Therapeutics Series B 30M
4/2014 NuCana BioMed Series B 57M
1/2003 HelloSoft Series A 11M
8/2002 Threshold Pharmaceuticals Series A 8.3M
10/2015 Audentes Therapeutics Series C 65M
1/2013 McPhy Venture Round 13.4M
9/2010 Inside Secure Series D 0
4/2000 BeamReach Networks Series A 13M
9/2010 Sorbent Therapeutics Series B 0
1/2007 Novexel Series B 65M
4/2015 Mirna Therapeutics Series D 0
10/2014 Aclaris Therapeutics Series B 21M
12/2007 Taptu Series A -
7/2015 Dauntless Pharmaceuticals Series A 12M
1/2004 Intransa Series C 8M
7/2011 SARcode Bioscience Series B 44M
1/2005 VoluBill Series C 0
9/2015 Aclaris Therapeutics Series C 40M
9/2001 HeadSprout Venture Round 0
1/2006 Movetis Venture Round -
1/2005 NextWave Pharmaceuticals Series A 10M
6/2000 Tensys Medical Series A -
3/2001 CellZome Series B 0
1/2004 Orexigen Therapeutics Series A 11M
1/2004 Threshold Pharmaceuticals Series B 41M
7/2013 Crocus Technology Series D 0
5/2020 Amplyx Pharmaceuticals Series C 0
5/2018 Rainier Therapeutics Series B 20M
1/2007 Movetis Series A 63.8M
3/2004 Reef Point Systems Series D 18M
3/2019 Karuna Therapeutics Series B 0
2/2000 Reef Point Systems Venture Round 22M
4/2013 Sorbent Therapeutics Venture Round 2.5M
5/2018 Neurana Pharmaceuticals Series A 0
1/2003 Intransa Series B 6M
1/2010 Aerie Pharmaceuticals Venture Round -
11/2007 Calient Technologies Venture Round 0
4/2004 Calient Technologies Series D 0
8/2008 InteKrin Series C 0
9/2006 Anthera Pharmaceuticals Venture Round 0
3/2004 UPEK Series A 20M
4/2010 MXP4 Series C 4M
7/2010 McPhy Venture Round 17.1M
11/2010 Verizon Ventures Series B 14M
1/2007 HeadSprout Series D 0
6/2018 ENYO Pharma Series B 46.8M
7/2020 Bolt Biotherapeutics Series C 93.5M
8/2015 Principia Biopharma Series B 15.3M
1/2009 Aclaris Therapeutics Venture Round -
1/2007 InteKrin Series B 0
1/1999 mNemoscience Venture Round -
4/2019 Inozyme Series A 67.4M
4/2014 Principia Biopharma Series B 50M
1/2016 NextCure Series A 67M
12/2007 Streamezzo Series C 22M
11/2017 Y-mAbs Therapeutics Private Equity Round 0
2/2002 Intransa Venture Round 10M
1/2001 Humanigen Venture Round -
1/2009 Galera Therapeutics Venture Round -
2/2015 Chiasma Series E 70M
7/2006 Calient Technologies Venture Round 0
1/2010 Crescendo Biologics Series A 0
3/2012 Enovix Series C 15M
3/2017 Antiva Biosciences Series C 22M
1/2004 Calient Technologies Series D 20M
9/2018 Galera Therapeutics Series C 70M
11/2010 ConteXtream Series B 14M
1/2007 Hyperion Therapeutics Series A -
12/2018 XyloCor Therapeutics Series A 17M
5/2014 LYSOGENE Series A 22M
11/2015 ObsEva Series B 60M
7/2001 ClarITeam Venture Round 12.2M
5/1999 Nishan Systems Series A 0
5/2017 AFYX Therapeutics Series A 17.6M
6/2009 Hyperion Therapeutics Series C 60M
3/2007 Phenomix Series C 55M
9/2006 Cortina Systems Series D 132M
6/2003 Phenomix Series A 11.6M
11/2015 First Aid Shot Therapy Series C 24M
5/2017 Iterum Therapeutics Series B 65M
1/2002 OpenReach Series B 31M
12/2004 Prestwick Pharmaceuticals Series B 37M
9/2022 RayzeBio Series D 160M
3/2001 White Pajama Venture Round 43M
7/2009 Stentys Series B 22.2M
8/2015 Antiva Biosciences Series B 16M
3/2021 XyloCor Therapeutics Series A 0
1/2013 IVERIC bio Venture Round -
2/2002 Salira Optical Network Systems Venture Round 7M
1/2002 BeamReach Networks Series B 0
6/2020 Checkmate Pharmaceuticals Series C 85M
11/2005 Inside Secure Series A 10.9M
4/2014 NuCana Series B 0
7/2011 SpineVision Venture Round 0
6/2009 CoAxia Series D 21.5M
2/2007 Trius Therapeutics Series A 20M
1/2001 Cotherix Venture Round -
12/2014 Audentes Therapeutics Series B 42.5M
10/2003 Network Physics Venture Round 0
9/2010 Cebix Venture Round 16M
1/2008 Amarin Post-IPO Equity -
6/2015 Crocus Technology Series E 21M
10/2012 Cebix Series B 0
6/2007 ConteXtream Series A 9.6M
5/2019 CinCor Pharma Series A 50M
10/2012 CrestaTech Venture Round 1.4M
4/2012 CrestaTech Venture Round 13M
4/2013 ConteXtream Venture Round 217k
10/2008 Crocus Technology Series B 15.9M
8/2020 Aerovate Therapeutics Series A 72.6M
11/2003 Catalyst Bioscience Series A 10.2M
4/2007 Ascenta Therapeutics Series C 50M
7/2006 Ocera Therapeutics Series B 12M
10/2001 Avaki Series A 10M
7/2012 Alimera Sciences Post-IPO Equity 40M
1/2016 Dauntless Pharmaceuticals Series A -
1/2019 Promedior Venture Round -
12/2012 Salveo Specialty Pharmacy Venture Round -
3/2008 Wyplay Series B 15.6M
7/2004 Vitra Bioscience Venture Round 5.5M
1/2015 Vestagen Technical Textiles Venture Round 800k
5/2010 Wyplay Series C 9M
10/2003 Cotherix Series C 55M
10/2012 NextWave Pharmaceuticals Venture Round 1.8M
6/2006 Crocus Technology Series A 17M
7/2012 Histogenics Series C 49M
1/2010 Laszlo Systems Venture Round 3M
2/2014 First Aid Shot Therapy Series B 7M
2/2007 PhyFlex Networks Private Equity Round 0
6/2011 Avantium Venture Round 0
12/2014 Histogenics Post-IPO Equity 0
2/2000 Mondo Media Series B 20M
12/2012 Labrys Biologics Venture Round 14.6M
5/2009 Streamezzo Series D 5.5M
1/2020 NorthSea Therapeutics Series B 40M
2/2018 Merus Post-IPO Equity 55.8M
7/2012 Guavus Series C 15M
5/2009 Marinus Pharmaceuticals Series B 20M
9/2017 Entasis Therapeutics Series B 31.9M
2/2006 Catalyst Biosciences Series B 30M
8/2015 Checkmate Pharmaceuticals Series A 20M
1/2013 Labrys Biologics Series A 31M
7/2004 Phenomix Series A 2M
6/2003 Prestwick Pharmaceuticals Series A 15M
2/2018 Kiniksa Pharmaceuticals Series C 200M
8/2008 Anthera Pharmaceuticals Venture Round 0
3/2015 aTyr Pharma Series E 76M
2/2007 NextWave Pharmaceuticals Series B 40M
1/2003 Orexo Series B 22.4M
1/2000 Theradiag Series A 4.6M
8/2007 Prestwick Pharmaceuticals Venture Round 20M
4/2006 Network Physics Venture Round 8.6M
9/2007 Hyperion Therapeutics Series B 40M
1/2004 Webdialogs Series A 1.9M
1/2017 InCarda Therapeutics Venture Round -
4/2006 Streamezzo Series B 0
1/2005 Sorbent Therapeutics Venture Round -
1/2004 PhyFlex Networks Venture Round 17.5M
8/2014 Guavus Series E 20M
4/2015 Natera Series F 0
11/2001 Laszlo Systems Seed Round 1M
8/2012 Sorbent Therapeutics Series C 18.1M
3/2000 Fresher Information Series A 20M
2/2017 Dauntless Pharmaceuticals Series A 25M
12/2013 Vestagen Technical Textiles Series A 7.3M
12/2020 Atsena Therapeutics Series A 0
4/2000 CornerHardware Series B 21M
10/2019 Aeovian Pharmaceuticals Series A 0
7/2018 Antiva Biosciences Series C 15M
9/2000 Sharing Technologies Series C 9M
1/2011 NextWave Pharmaceuticals Series C 45M
10/2006 Prestwick Pharmaceuticals Series C 60M
10/2014 Invitae Series F 0
11/2018 Visen Pharmaceuticals Series A 0
5/1998 Actelion Pharmaceuticals Venture Round 12M
7/2009 Intellikine Series B 51M
12/2008 Catalyst Biosciences Post-IPO Equity 40M
9/2006 Alvine Pharmaceuticals Series A 21.5M
6/2010 KXEN Series D 8M
4/2015 Merus Series C 79.1M
10/2018 VelosBio Series A 58M
3/2005 Humanigen Series B 20M
9/2008 Humanigen Series D 0
11/2003 Saegis Pharmaceuticals Series B 30M
12/2017 Pionyr Immunotherapeutics Series B 0
8/2014 Civitas Therapeutics Series C 0
11/2017 Medeor Therapeutics Series B 0
4/2023 Antiva Biosciences Series E 0
9/2007 VoluBill Series D 0
3/2004 CareX SA Series B 32M
3/2002 Phenomix Series A 12M
1/2004 Novacea Series C 35M
11/2002 Novacea Series B 36M
6/2020 Athira Pharma Series B 85M
8/2017 Amplyx Pharmaceuticals Series C 0
3/2020 Akouos Series B 105M
8/2018 Akouos Series A 25.1M
3/2021 Gyroscope Therapeutics Series C 0
1/2001 Mondo Media Series C 17M
3/2014 ZS Pharma Series D 0
10/2012 Aclaris Therapeutics Series A 21M
8/2017 Apellis Pharmaceuticals Series E 0
6/2017 Checkmate Pharmaceuticals Series B 27M
3/2017 Rainier Therapeutics Series B 30M
12/2021 NorthSea Therapeutics Series C 0
7/2020 VelosBio Series B 137M
10/2021 CinCor Pharma Series B 0
1/2021 Vera Therapeutics Series C 0
11/2021 Antiva Biosciences Series D 0
11/2018 NextCure Series B 93M
10/2021 Quanta Therapeutics Series C 60M
2/2014 Versartis Series E 55M
1/2018 Quanta Therapeutics Venture Round -
9/2004 Cellective Therapeutics Series A 27.5M
9/2006 Alvine Pharmaceuticals Series A 8M
4/2000 Radix Wireless Series A 13M
1/2013 Sophiris Bio Venture Round -
1/2012 TESARO Series C -
10/2007 Catalyst Mobile Series B 10M
1/2019 NorthSea Therapeutics Venture Round -
4/2013 Auris Medical Series C 51M
12/2022 ArriVent Biopharma Series B 0
3/2011 Aerie Pharmaceuticals Series B 41.4M
10/2008 Cebix Series A 2.9M
4/2015 Edge Therapeutics Series C 56M
1/2001 Saegis Pharmaceuticals Series A 14M
1/1999 Entelos Venture Round -
1/2001 Vitra Bioscience Venture Round -
10/2009 UPEK Venture Round 6.2M
5/2003 Theradiag Series B 10.4M
1/2013 Prothena Post-IPO Equity -
1/2015 Iterum Therapeutics Venture Round -
6/2007 Intellikine Series B 30M
1/2015 NextCure Venture Round -
1/2014 Ziarco Venture Round -
8/2013 ObsEva Series A 34.5M
1/2017 Ascendis Pharma Post-IPO Equity -
11/1999 eStar Series A 2.2M
1/2007 Anza Therapeutics Venture Round -
12/2004 Novexel Series A 53.6M
10/2005 Marinus Pharmaceuticals Series A 29.4M
1/2013 Marinus Pharmaceuticals Series C 21M
6/2001 Transcept Pharmaceuticals Series A -
12/2007 PregLem Series B 32.2M
5/2013 First Aid Shot Therapy Series A -
1/2014 Natera Venture Round -
4/2003 BeamReach Networks Series C 15M
1/2003 Ascenta Therapeutics Series A 6M
1/2007 Coherus Biosciences Venture Round -
10/2012 Mirna Therapeutics Series C 34.5M
1/2013 Guavus Series D 39M
10/2011 Guavus Series B 25M
12/2008 Humanigen Series D 12M
3/2002 KXEN Series B 2M
1/2001 Anesiva Venture Round -
4/2005 Phenomix Series B 20M
1/1999 InterMune Venture Round -
1/2014 Innocoll Holdings Venture Round -
1/2004 Cellective BioTherapy Venture Round -
12/1999 Nishan Systems Series B 0
10/2019 Intrepida Bio Venture Round 9.5M
11/2016 Galera Therapeutics Series B 15M
6/2010 Vicept Therapeutics Series A 16M
5/2014 Coherus Biosciences Series C 54.7M
4/2007 DiObex Series B 24M
2/2002 Sequence Design Venture Round 20M
6/2003 Humanigen Seed Round 4M
9/2012 Catalyst Biosciences Post-IPO Equity 13.4M
12/2014 Ascendis Pharma Series D 60M
12/2013 Invitae Series E 0
3/2016 Iterum Therapeutics plc Series A 40M
1/2009 Vicept Therapeutics Venture Round -
1/2004 OpenReach Venture Round 7M
9/2005 DiObex Series A 7.1M
10/2022 immatics biotechnologies Post-IPO Equity 0
5/2014 Spark Therapeutics Series B 72.8M
1/1998 Seagen Venture Round -
12/2021 NorthSea Therapeutics Series C 0
11/2021 Antiva Biosciences Series D 0
10/2021 Quanta Therapeutics Series C 0
10/2021 CinCor Pharma Series B 0
3/2021 Gyroscope Therapeutics Series C 0
3/2021 XyloCor Therapeutics Series A 0
1/2021 Vera Therapeutics Series C 0
1/2021 Visen Pharmaceuticals Series B 0
12/2020 Atsena Therapeutics Series A 0
8/2020 Aerovate Therapeutics Series A 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research
CoBee's Logo
Copyright © CoBee 2022. All Rights Reserved.